证券记录 · 已归档季度
CMPX
Compass Therapeutics, Inc. · Healthcare · Biotechnology
15被追踪持有人
0Δ持有人
39.02M持有股份
$136.56M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +26.4% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +4 | 68.60M | $150.73M | +11 | −7 |
| Q1 2026 | 79 | +9 | 59.45M | $314.31M | +12 | −3 |
| Q4 2025 | 70 | +2 | 49.56M | $266.12M | +3 | −1 |
| Q3 2025 | 15 | 0 | 39.02M | $136.56M | +1 | −1 |
| Q2 2025 | 12 | +1 | 25.65M | $66.69M | +1 | — |
| Q1 2025 | 8 | +1 | 9.48M | $18.01M | +1 | — |
| Q4 2024 | 7 | -1 | 10.74M | $15.57M | — | −1 |
| Q3 2024 | 7 | -1 | 14.12M | $25.99M | — | −1 |
| Q2 2024 | 8 | — | 14.75M | $14.75M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 7.37M | +14.9% | $25.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 7.06M | +45.6% | $24.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 5.19M | +17.2% | $18.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 4.14M | +0.1% | $14.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 4.00M | — | $13.99M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 3.24M | +280.4% | $11.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (被动) | 3.11M | +57.6% | $10.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Geode Capital Management ✦ (被动) | 2.94M | +27.0% | $10.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 2.94M | +27.0% | $10.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 1.04M | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 1.04M | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Wellington Management ✦ | 318.12K | -8.6% | $1.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 233.27K | 新增 | $816,449 | 0.0% | New | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 186.95K | — | $654,333 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 79.00K | -64.8% | $276,500 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 59.15K | +22.1% | $207,019 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 56.59K | +20.6% | $199,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $816,449 | 0.0% |
已清仓
| Two Sigma Investments | $41,852 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 199 持有人, 172.39M 股份, $913.59M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据